Product
OCS-05
1 clinical trial
3 indications
Indication
optic neuritisIndication
Optic NeuritisIndication
DemyelinationClinical trial
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Tolerability of OCS-05 in Patients With Acute Optic NeuritisStatus: Recruiting, Estimated PCD: 2023-10-30